Physician profile
Matthew Deeths
NPI 1750345690
$1,328.58
in general payments reported to CMS, 2019-2025
15 companies · $308 in 2025
The $308 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $115 · 2022: $129 · 2023: $190 · 2024: $445 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $942.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $942.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $551.82 | 2019-2025 | Skyrizi |
| Novartis Pharmaceuticals Corporation | $130.31 | 2024-2025 | |
| Biofrontera INC. | $119.33 | 2019-2025 | Ameluz, Xepi, Bf-Rhodoled |
| Sun Pharmaceutical Industries INC. | $84.72 | 2023-2024 | Ilumya |
| Incyte Corporation | $69.48 | 2023-2025 | Opzelura |
| Ucb, INC. | $60.65 | 2023-2024 | Bimzelx, Cimzia |
| Lilly USA, LLC | $54.62 | 2022-2024 | Olumiant |
| Pfizer INC. | $47.73 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $45.41 | 2023-2024 | Sotyktu |
| Organogenesis INC. | $38.23 | 2023-2024 | Puraply |
| Janssen Biotech, INC. | $33.60 | 2022-2023 | Simponi Aria, Simponi, Stelara |
| Kyowa Kirin, INC. | $26.88 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $23.61 | 2022 | |
| Organon LLC | $22.75 | 2025 | Vtama |
| Amgen INC. | $19.44 | 2024 | Otezla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Deeths listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.